Baumer S.A

Baumer S.A

BALM3 · SA · Healthcare / Medical Instruments & Supplies

22.00BRL+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close22.00
Open22.00
Day Range22.00 – 22.00
52-Week Range18.66 – 30.00
Volume0
Market Cap215.26M
P/E (TTM)10.09
Forward P/E0.00
EPS2.18
Dividend Yield24.15%
Beta0.40
50-Day Avg25.97
200-Day Avg26.19

About

Baumer S.A., together with its subsidiaries, engages in the development, industrialization, trade, production, import, export, and technical assistance in products for hospitals and industries related to the health area in Brazil and internationally. The company offers orthopedic devices, such as conventional prosthesis, spine and neurosurgery, non-conventional prosthesis, trauma, and biomaterials; and hospital equipment, including CSSD, surgical center and ICU, and sterilization process monitoring. It also provides life science equipment comprising pharmaceutical production and research laboratory; bone regeneration consisting of structural, raw material, and specialties; and maintenance, sterilization process monitoring, rental, CME equipment management, technological update, and replacement parts, as well as inspection, qualification, and calibration services. In addition, the company offers the Baumer Academy platform for specialized courses in the areas of hospital equipment, bone regeneration, and orthopedic devices. Baumer S.A. was incorporated in 1952 and is headquartered in Pacaembu, Brazil.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Ruy Salvari Baumer
  • Employees0
  • HeadquartersAvenida Arnolfo Azevedo, 210, Pacaembu, SP, Brazil, 01236-030, Brazil
  • Websitehttps://www.baumer.com.br

Leadership

  • Mr. Ruy Salvari BaumerChairman, CEO & Chairman of the Executive Officers Board
  • Ms. Monica Salvari BaumerChief Investor Relations Officer & Member of the Executive Officers Board
  • Mr. Breno Correa Farago Jr.Member of the Executive Officers Board
  • Ms. Lourdes Maria A. Quaresma De CamargoMember of the Executive Officers Board
  • Mr. Jose Henrique Marques CamargoMember of the Executive Officers Board
  • Bruno Bueno Gamboa Salvari BaumerMember of the Executive Officers Board

Financials

Income Statement

Currency: BRL2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue40.28M45.65M53.94M65.11M65.30M74.06M85.20M94.81M93.51M99.75M108.70M116.30M112.04M113.11M109.75M119.80M149.31M325.95M267.64M329.09M169.95M194.39M213.73M
Growth (%)-+13.33%+18.14%+20.71%+0.30%+13.40%+15.05%+11.28%-1.37%+6.67%+8.97%+6.99%-3.66%+0.95%-2.96%+9.16%+24.63%+118.30%-17.89%+22.96%-48.36%+14.38%+9.95%
Cost of Revenue15.83M19.36M21.91M25.84M28.37M31.53M36.45M42.07M39.26M37.78M38.24M42.78M44.09M43.06M46.28M52.40M72.02M81.44M58.66M68.62M67.07M74.58M78.58M
Gross Profit24.46M26.29M32.02M39.27M36.94M42.52M48.75M52.74M54.25M61.96M70.46M73.51M67.96M70.05M63.47M67.40M77.29M244.51M208.98M260.47M102.88M119.81M135.15M
Gross Margin60.71%57.59%59.37%60.31%56.56%57.42%57.22%55.63%58.01%62.12%64.82%63.21%60.65%61.93%57.83%56.26%51.76%75.02%78.08%79.15%60.53%61.63%63.23%
Operating Expense22.05M22.50M26.80M32.52M33.47M35.25M42.07M45.46M44.31M48.83M50.26M55.23M46.69M61.25M61.02M61.47M66.78M222.34M194.11M253.67M80.17M91.06M93.83M
Operating Income2.40M3.79M5.22M6.75M3.47M7.27M6.68M7.29M9.94M13.13M20.20M18.28M21.26M8.79M2.45M5.93M10.51M22.17M14.87M6.80M22.71M28.75M41.32M
Operating Margin5.97%8.30%9.68%10.36%5.31%9.82%7.84%7.68%10.63%13.17%18.58%15.72%18.98%7.77%2.23%4.95%7.04%6.80%5.55%2.07%13.36%14.79%19.33%
EBITDA2.90M4.07M5.22M6.75M3.47M9.42M6.76M10.14M13.72M18.13M21.29M19.34M16.36M12.22M6.62M11.14M15.08M25.32M20.34M21.99M26.70M55.93M46.86M
EBITDA Margin7.21%8.92%9.68%10.36%5.31%12.72%7.94%10.70%14.67%18.17%19.59%16.63%14.60%10.80%6.03%9.30%10.10%7.77%7.60%6.68%15.71%28.77%21.92%
Net Income872.00K1.27M3.38M5.42M1.83M4.21M1.98M3.72M6.93M8.46M13.13M11.50M14.35M3.02M675.00K2.75M4.19M16.43M10.13M5.71M8.94M31.61M18.08M
Net Income Margin2.16%2.79%6.27%8.33%2.81%5.69%2.32%3.92%7.41%8.48%12.08%9.89%12.81%2.67%0.62%2.30%2.81%5.04%3.79%1.73%5.26%16.26%8.46%
R&D---2.75M3.17M3.65M4.44M4.19M4.85M4.98M5.26M6.02M5.68M7.08M6.38M4.63M4.76M4.39M5.67M6.14M5.82M6.38M6.18M
R&D as % of Total Revenue---4.22%4.86%4.93%5.21%4.42%5.18%4.99%4.84%5.18%5.07%6.26%5.82%3.86%3.19%1.35%2.12%1.87%3.43%3.28%2.89%
Interest Expense494.00K1.04M465.00K1.04M1.12M2.88M1.59M1.41M252.00K1.27M2.46M4.00M5.86M8.31M1.22M2.29M1.18M970.00K1.64M1.45M9.56M10.65M13.16M
Interest Expense % of Total Revenue1.23%2.27%0.86%1.60%1.72%3.90%1.87%1.49%0.27%1.27%2.26%3.44%5.23%7.35%1.11%1.91%0.79%0.30%0.61%0.44%5.63%5.48%6.16%

Balance Sheet

Currency: BRL2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets34.35M40.33M46.43M51.69M53.16M63.21M72.13M86.58M88.43M100.51M124.59M136.89M161.82M170.69M180.84M189.89M190.59M214.53M228.13M248.61M249.93M286.67M274.81M
Total Liabilities14.29M18.73M21.46M23.06M23.00M25.36M32.89M40.27M34.85M37.78M48.14M54.85M66.90M72.54M80.31M85.72M82.46M93.28M96.41M114.02M104.33M112.13M130.82M
Total Equity16.77M18.03M17.10M24.50M26.11M32.36M33.89M41.18M47.19M55.68M68.67M73.82M86.17M87.63M88.57M94.03M100.52M113.08M130.22M133.54M144.24M177.96M153.04M
Cash3.31M7.34M7.74M1.88M1.10M1.27M5.22M1.77M2.13M3.06M7.14M10.61M6.96M5.06M4.20M2.96M5.66M16.87M12.98M8.86M13.86M16.86M16.14M
Total Debt1.38M444.00K816.00K633.00K-5.55M7.16M8.91M5.91M12.66M19.15M21.42M27.52M35.09M32.10M31.96M30.89M18.71M21.59M25.65M20.30M16.73M21.50M
Net Debt-1.94M-6.90M-6.93M-1.25M-1.10M-1.27M1.94M7.14M3.78M9.60M12.01M10.81M20.56M30.04M27.90M29.00M25.23M1.84M8.61M16.79M6.44M-137.00K5.36M

Cash Flow

Currency: BRL2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow578.00K3.24M201.00K7.08M1.50M8.87M5.03M4.69M766.00K5.53M-2.87M14.53M26.32M17.64M3.13M25.59M31.28M66.81M
Investing Cash Flow-1.34M-1.74M-2.06M-3.55M-4.78M-2.58M-4.18M-2.63M-5.86M-1.57M-3.54M-8.38M-7.46M-4.17M-3.32M-5.30M-2.85M-20.04M
Financing Cash Flow1.87M1.75M-2.81M486.00K977.00K4.54M-1.71M2.64M2.76M-5.31M-355.00K-2.03M-651.00K-1.10M-489.00K-4.15M-11.06M-56.28M
Capital Expenditure2.42M1.79M3.72M4.27M5.09M3.50M4.41M3.22M6.22M1.87M4.37M7.46M5.55M4.81M6.08M5.42M7.73M12.87M
Free Cash Flow-1.84M1.45M-3.52M2.81M-3.59M5.37M628.00K1.48M-5.45M3.67M-7.24M7.06M20.77M12.82M-2.94M20.17M23.54M53.94M
Dividends Paid---2.09M1.23M1.94M3.29M3.13M4.42M2.32M2.16M2.20M2.31M4.85M4.80M4.24M7.48M61.05M
FCF to OCF-317.99%44.69%-1752.74%39.69%-238.66%60.53%12.48%31.49%-711.88%66.23%252.13%48.62%78.91%72.72%-94.00%78.81%75.27%80.73%
Dividend Paid to FCF---74.47%-34.40%36.22%524.36%211.50%-80.96%63.25%-29.85%31.16%11.11%37.79%-162.85%21.02%31.79%113.18%

Key Statistics & Ratios

Market Cap215.26M
Enterprise Value157.38M
Trailing P/E10.09
Forward P/E0.00
Price / Sales1.05
Price / Book1.51
EPS2.18
Book Value17.16
Revenue (TTM)205.24M
Gross Profit (TTM)131.05M
EBITDA40.63M
Profit Margin11.01%
Operating Margin14.12%
Return on Equity14.83%
Return on Assets7.46%
Shares Outstanding4.89M
Shares Float3.48M
Beta0.40
Dividend Yield24.15%
Dividend Rate6.28
Payout Ratio258.79%

Dividends

20253×
3.07Dec 17, 20250.93Oct 2, 20250.64May 6, 2025
20232×
0.03Apr 28, 20230.11Jan 4, 2023
20221×
0.06Apr 29, 2022
20211×
0.09Apr 30, 2021
20202×
0.07Aug 5, 20200.23Apr 29, 2020
20191×
0.14May 2, 2019
20181×
0.03Apr 30, 2018
20171×
0.04Apr 28, 2017
20161×
0.34Apr 29, 2016
20152×
0.09May 1, 20150.35Apr 30, 2015
20142×
0.92May 1, 20140.42Apr 30, 2014
20131×
0.15Apr 26, 2013
20121×
0.03May 1, 2012
20111×
0.03Apr 29, 2011
20091×
0.03Apr 29, 2009
20081×
0.20May 1, 2008

Stock Splits

  • May 2, 201410:1
  • Jul 30, 20082:1
  • May 30, 20051:1000